Inclusion Criteria:  Age ≥18 years old, ≤75 years old; Meet the diagnostic criteria for cardiac neurosis: the patient has palpitations, precordial pain, chest tightness, shortness of breath, dyspnea, dizziness, insomnia and dreaminess, cold hands and feet, hyperhidrosis and other cardiovascular symptoms and neurological disorders; Meet the diagnostic criteria of Heyisheng type palpitations in Mongolian medicine; There is no objective diagnosis of coronary heart disease (in accordance with any of the following): ①The activity flat test is negative; ② Coronary angiography or coronary CTA suggests that the lumen stenosis is ≤50%; ③ Exercise or drug load radionuclide examination results suggest no myocardial ischemia; The patient did not take anti-anxiety and depression drugs or psychotropic drugs within 2 weeks before enrollment; agrees to voluntarily participate in the study and signs an informed consent form .  Exclusion Criteria:  Accompanied by organic heart disease, severe cardiopulmonary insufficiency; Poor hypertension control (systolic blood pressure ≥160mmHg or diastolic blood pressure ≥100mmHg after treatment); Those with malignant arrhythmia; Those who use pacemakers; Patients with hyperthyroidism; Combined with severe liver and kidney damage (ALT, AST or TBIL> 2 times the upper limit of the normal reference value, or Cr> 1.5 times the upper limit of the normal reference value); People with serious primary diseases such as hematopoietic system or mental illness; SAS≥70; SDS≥73; Accompanying any other serious diseases or conditions such as malignant tumors; Women during pregnancy and lactation; People with allergies or allergies to the known ingredients of the research drug; Participated in other clinical research in the past 3 months; According to the judgment of the investigator, the subject is not suitable for research observation.